74.15
Precedente Chiudi:
$70.74
Aprire:
$71.36
Volume 24 ore:
90,386
Relative Volume:
0.64
Capitalizzazione di mercato:
$407.93M
Reddito:
$223.71M
Utile/perdita netta:
$-250.31M
Rapporto P/E:
-1.5974
EPS:
-46.42
Flusso di cassa netto:
$41.44M
1 W Prestazione:
+3.47%
1M Prestazione:
+14.15%
6M Prestazione:
-34.33%
1 anno Prestazione:
-44.54%
Mesa Laboratories Inc Stock (MLAB) Company Profile
Nome
Mesa Laboratories Inc
Settore
Industria
Telefono
(303) 987-8000
Indirizzo
12100 W 6TH AVE, LAKEWOOD
Confronta MLAB con altri titoli
Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
---|---|---|---|---|---|---|
![]()
MLAB
Mesa Laboratories Inc
|
74.15 | 393.24M | 223.71M | -250.31M | 41.44M | -46.42 |
![]()
GRMN
Garmin Ltd
|
246.74 | 47.99B | 6.76B | 1.57B | 1.13B | 8.105 |
![]()
KEYS
Keysight Technologies Inc
|
162.41 | 28.33B | 5.24B | 544.00M | 1.42B | 3.1389 |
![]()
TDY
Teledyne Technologies Inc
|
561.49 | 26.82B | 5.92B | 860.50M | 953.00M | 18.15 |
![]()
TRMB
Trimble Inc
|
77.87 | 18.57B | 3.58B | 286.70M | 287.10M | 1.171 |
![]()
COHR
Coherent Corp
|
115.96 | 17.16B | 5.60B | 96.54M | 256.25M | -0.23 |
Mesa Laboratories Inc Stock (MLAB) Upgrades & Downgrades
Data | Azione | Analista | Modifica della valutazione |
---|---|---|---|
2025-08-07 | Aggiornamento | Wells Fargo | Underweight → Equal Weight |
2024-08-28 | Iniziato | Wells Fargo | Underweight |
2024-01-04 | Aggiornamento | Evercore ISI | In-line → Outperform |
2021-01-04 | Downgrade | Evercore ISI | Outperform → In-line |
2020-11-10 | Iniziato | KeyBanc Capital Markets | Sector Weight |
2020-10-02 | Iniziato | JP Morgan | Neutral |
2019-12-04 | Iniziato | Jefferies | Buy |
2019-08-26 | Iniziato | Evercore ISI | Outperform |
2016-06-10 | Downgrade | Sidoti | Buy → Neutral |
Mostra tutto
Mesa Laboratories Inc Borsa (MLAB) Ultime notizie
What analysts say about Mesa Laboratories Inc stockInflation Impact on Stocks & Free Smart Trading Classes - earlytimes.in
Is Mesa Laboratories Inc. stock reversal real or fakeJuly 2025 Short Interest & AI Enhanced Execution Alerts - newser.com
Will Mesa Laboratories Inc. stock recover after recent dropJuly 2025 Closing Moves & Consistent Income Trade Ideas - newser.com
Published on: 2025-10-13 08:05:40 - newser.com
Earnings visualization tools for Mesa Laboratories Inc.July 2025 Technicals & Verified Entry Point Signals - newser.com
Mesa Laboratories (NASDAQ:MLAB) Given Sell (D) Rating at Weiss Ratings - MarketBeat
Published on: 2025-10-10 05:34:37 - newser.com
Tools to assess Mesa Laboratories Inc.’s risk profileDividend Hike & Weekly High Return Stock Forecasts - newser.com
How to integrate Mesa Laboratories Inc. into portfolio analysis toolsJuly 2025 Market Mood & Target Return Focused Picks - newser.com
Why Mesa Laboratories Inc. stock remains on watchlistsTrade Performance Summary & Weekly Top Stock Performers List - newser.com
RxSight (NASDAQ:RXST) vs. Mesa Laboratories (NASDAQ:MLAB) Head-To-Head Analysis - Defense World
Will Mesa Laboratories Inc. rebound enough to break even2025 Earnings Impact & Weekly High Potential Stock Alerts - newser.com
Can technical indicators confirm Mesa Laboratories Inc.’s reversalJuly 2025 Action & High Accuracy Trade Signal Alerts - newser.com
How to use Fibonacci retracement on Mesa Laboratories Inc.Gold Moves & Long-Term Growth Portfolio Plans - newser.com
Biological Indicator Market Overall Study Report 2025-2032 | 3M Company, STERIS plc, Getinge AB., Mesa Laboratories - industrytoday.co.uk
Mesa Laboratories (NASDAQ:MLAB) Share Price Crosses Below Two Hundred Day Moving AverageShould You Sell? - MarketBeat
Mesa Laboratories (NASDAQ:MLAB) Has Affirmed Its Dividend Of $0.16 - Sahm
Why medical device manufacturers should rethink sterilization assurance - SelectScience
Real time pattern detection on Mesa Laboratories Inc. stockJuly 2025 Movers & Smart Swing Trading Techniques - newser.com
Can Mesa Laboratories Inc. (MLI) stock sustain margin levelsJuly 2025 Selloffs & AI Enhanced Trading Alerts - newser.com
Mesa Laboratories Inc. recovery potential after sell offInsider Selling & Long-Term Capital Growth Ideas - newser.com
Mesa Laboratories, Inc. Plans Quarterly Dividend of $0.16 (NASDAQ:MLAB) - MarketBeat
Mesa Laboratories, Inc. to Announce Second Quarter Results on November 6, 2025 - The Manila Times
Banco Santander Chile: Third Quarter 2025 Analyst and Investor Webcast / Conference Call - The Manila Times
GTT: Monthly disclosure of the total number of voting rights and shares composing the share capital - The Manila Times
Landsbankinn hf.: Landsbankinn concludes market-making agreements for covered bonds - The Manila Times
Mesa Laboratories, Inc. Declares Quarterly Dividend, Payable on December 15, 2025 - MarketScreener
Q2 FY2026 Results Nov 6, 2025 — Mesa Laboratories to Issue Second-Quarter Financial Release - Stock Titan
MESA LABS DECLARES QUARTERLY DIVIDEND - The Manila Times
Mesa Laboratories Keeps Quarterly Dividend at $0.16 a Share, Payable Dec. 15 to Holders of Record on Nov. 28 - MarketScreener
$0.16 per share: Mesa Labs Declares Quarterly Dividend Payable Dec 15; Record Date Nov 28 - Stock Titan
Why Mesa Laboratories Inc. stock is popular among millennials2025 Sector Review & Risk Adjusted Buy/Sell Alerts - newser.com
Published on: 2025-10-03 01:48:44 - newser.com
Combining price and volume data for Mesa Laboratories Inc.Options Play & Precise Trade Entry Recommendations - newser.com
Published on: 2025-09-29 17:41:02 - newser.com
Mesa Laboratories Inc MLI Stock Analysis and ForecastMarket Correction Analysis & Big Returns Low Cost - earlytimes.in
Mesa Laboratories Inc Azioni (MLAB) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Mesa Laboratories Inc Azioni (MLAB) insider trading
Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
---|---|---|---|---|---|---|---|
Sullivan John James | Director |
Aug 15 '25 |
Option Exercise |
0.00 |
1,404 |
0 |
27,282 |
Hall Shannon | Director |
Aug 15 '25 |
Option Exercise |
0.00 |
1,404 |
0 |
4,189 |
Tripeny R Tony | Director |
Aug 15 '25 |
Option Exercise |
0.00 |
1,404 |
0 |
4,083 |
Capone Mark Christopher | Director |
Aug 15 '25 |
Option Exercise |
0.00 |
1,404 |
0 |
2,128 |
Alltoft Jennifer Sadie | Director |
Aug 15 '25 |
Option Exercise |
0.00 |
1,404 |
0 |
4,878 |
Sakys John | CFO |
Jun 21 '25 |
Option Exercise |
95.82 |
1,036 |
99,270 |
15,498 |
Archbold Brian David | SVP Operations |
Jun 21 '25 |
Option Exercise |
95.82 |
844 |
80,872 |
2,792 |
Owens Gary M | President and CEO |
Jun 21 '25 |
Option Exercise |
95.82 |
3,301 |
316,302 |
54,022 |
Owens Gary M | President and CEO |
Jun 18 '25 |
Option Exercise |
92.99 |
8,707 |
809,664 |
54,531 |
Archbold Brian David | SVP Operations |
Jun 18 '25 |
Option Exercise |
92.99 |
2,556 |
237,682 |
3,114 |
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):